Anixa Biosciences Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders July 20, 2020
Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office July 10, 2020
Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds July 6, 2020
Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline July 2, 2020
Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays June 1, 2020
Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate May 4, 2020
Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Biomarker Insights Highlighting Cchekâ„¢ Liquid Biopsy Technology April 23, 2020
Anixa Biosciences and OntoChem Announce Collaboration to Develop Novel COVID-19 Therapeutics April 20, 2020
Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program February 12, 2020